Pemetrexed 500mg Injection

Pemetrexed is an antifolate chemotherapy used in selected non-squamous non-small-cell lung cancer and malignant pleural mesothelioma regimens. The tumour type and treatment combination determine its role.
The oncology team prepares and gives the medicine as an intravenous infusion over 10 minutes. Folic acid is started seven days before the first infusion; intramuscular vitamin B12 and a corticosteroid regimen are also arranged to reduce treatment toxicity.
Inhibition of folate-dependent enzymes limits synthesis of DNA and RNA precursors needed by proliferating cells.
Fatigue, nausea, appetite loss, mouth sores, rash and reduced blood-cell counts can occur.
Blood counts and renal function must be assessed before cycles. Fever, infection, bleeding or severe diarrhoea needs prompt review; impaired renal clearance substantially increases toxicity.
Can slow tumour growth in selected non-squamous lung cancer or malignant pleural mesothelioma regimens.
It reduces the severity of pemetrexed toxicity and is not an optional general supplement.
Do not substitute independently; the labelled toxicity-reduction regimen uses intramuscular B12.
Dexamethasone is used in the treatment protocol to reduce skin reactions.
Any fever during a period of low blood counts should be assessed promptly under the clinic's emergency plan.
NSAIDs can affect pemetrexed handling, particularly with reduced kidney function; timing may need adjustment.
No. Histology, including squamous versus non-squamous disease, affects suitability.
The oncology team must evaluate renal function before deciding on treatment.
Continue folic acid throughout treatment and for 21 days after the last pemetrexed dose. Do not stop it on the final infusion day.
Antifolate: a drug interfering with folate-dependent metabolism. Neutropenia: a low neutrophil count. Mesothelioma: a cancer arising from mesothelial surfaces., AR: Pemetrexed حقن, FR: Pemetrexed, PT: Pemetrexed injeção, ES: Pemetrexed inyección, RU: Pemetrexed инъекция, ID: Pemetrexed injeksi, VI: Pemetrexed thuốc tiêm, MS: Pemetrexed suntikan, TL: Pemetrexed iniksyon, ZH-SG: Pemetrexed 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Pemetrexed 500mg Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pemetrexed 500mg Injection